🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Addressing cognitive decline in #BladderCancer patients through prehab and rehab. Sarah P. Psutka MD MS Fred Hutch Cancer Center joins Zach Klaassen Georgia Cancer Center to share how treatments can impact cognitive function, affecting up to 1/3 of patients and highlights strategies like brain training,

Dr. Sia Daneshmand, M.D. and Dr. Porter are kicking off the meeting! Looking forward to learning from the giants in the field of #testiscancer!

📢Published online today in Journal of Endourology! 🏥5 canters > 158 cases After PSM > MIS vs open Nx: ⬇️EBL and LOS ➡️90d complications and readmissions 0⃣90d mortality Dr. Hooman Djaladat Farshad Sheybaee Moghaddam 🔗liebertpub.com/doi/10.1089/en…

Today is national Thank a Resident Day, and we would like to give a big shout out to our past, current, and incoming trainees who continue to show their dedication every day! 💜💛 #UWUrology

Safety and tolerability of TAR-200 monotherapy in patients with BCG-unresponsive high-risk #NMIBC in #SUNRISE-1. Sia Daneshmand, M.D. Keck School of Medicine of USC joins Zach Klaassen Georgia Cancer Center to discuss on UroToday. The Phase IIb study demonstrates an impressive 83.5% complete response rate

It was an honor presenting the Society of Urologic Oncology #SUO lecture European Association of Urology (EAU) #EAU25 on updates in ERAS. New guidelines coming in 2025! Saum Ghodoussipour ERAS® Society. Thanks you jim catto Kari Tikkinen Badrinath Konety, MD, MBA

Delighted to share our new paper on UTUC 📊 883 pts (15% NAC) from ROBUUST 2.0 🚨 ypN+: worse 5yr OS vs. pN+ (20% vs. 31%) 📉 All ypN+ had mets at 1yr, 13% pN+ mets-free 🔄 Recurrence patterns vary by nodal/NAC 🔗authors.elsevier.com/c/1kpgh3r93ngf… Dr. Hooman Djaladat USC Urology Urologic Oncology

.Sia Daneshmand, M.D., USC Urology, discusses recent updates in bladder cancer guidelines, focusing on the 2024 NCCN and AUA recommendations. #Urology #AUA2024 #Bladder

Gain insights on the latest data on advanced drug delivery techniques, targeted agents, and immunotherapy for #bladdercancer with Drs. Sia Daneshmand, M.D., Laura Bukavina, Matt Galsky. 4/28 at 7:30 AM PDT. Hosted by PeerView at #AUA25. bit.ly/BL25-T

Join the legendary Sia Daneshmand, M.D. at #AUA2025 for an expert take on advancing bladder cancer care. Proud to be part of his incredible team Leilei Xia Chirag Doshi Farshad Sheybaee Moghaddam Alireza Ghoreifi, MD USC Urology Amer. Urol. Assn.

The effect of enhanced recovery after surgery on oncologic outcome following radical cystectomy for urothelial bladder carcinoma. #AuthorCommentary Does ERAS impact oncologic outcomes after radical cystectomy? A study of 2111 patients found ERAS reduces hospital stay & improves

Don't miss Dr. Hooman Djaladat at #AUA2025 as he presents our experience from the Vesicopexy trial. Join us for insights during the 'Clinical Trials in Progress: Prostate & Kidney Cancer' session. USC Urology Amer. Urol. Assn.

This year's SWIU outstanding resident award will be presented to Dr Chloe Peters at the SWIU-AUA breakfast! Congratulations!🌟 UW Urology

Just published in ICUrology ➡️Post-hoc analysis of PUBMIC trial >> learning curve effect in surgical trials 📉Temporal improvement in 90d stoma complications 📉Downtrending of clinical and surgery for PSH Farshad Sheybaee Moghaddam Dr. Hooman Djaladat 🔗 icurology.org/DOIx.php?id=10…

Mathew Sorensen UW Urology Congrats on the well deserved award for substantial contributions to the SAU. Society of Academic Urologists

UW Urology Tova Weiss, MD #AUA2025 Dr. Tova Weiss presenting her device to prevent catheter trauma at Innovation Nexus. Congratulations

Next up, check out #URO92 with Sia Daneshmand, M.D. to review the modern management of stage 2 seminoma Testicular Cancer Testicular Cancer Society #testicularcancerawarenessmonth open.spotify.com/episode/6PmVV5…

Happening now: An all 🌟 panel of experts is sharing insights on precision medicine and the evolving landscape of bladder cancer care at #AUA2025 Sia Daneshmand, M.D. Laura Bukavina Sarah P. Psutka MD MS Matt Galsky PeerView Bladder Cancer Advocacy Network

Thrilled to see the phase 3 RCT of vesicopexy on urinary continence and QOL following RARP, led by Dr. Hooman Djaladat, presented at the Clinical Trials in Progress session! A truly impactful study on a critical topic. #AUA25 Alireza Ghoreifi, MD Farshad Sheybaee Moghaddam USC Urology

Great job by my colleagues Farshad Sheybaee Moghaddam Rashid K. Sayyid and the ROBUUST collaborative group!